Singapore Exchange Limited (S68):企業の財務・戦略的SWOT分析

◆英語タイトル:Singapore Exchange Limited (S68) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C10748
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Singapore Exchange Limited (S68) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Singapore Exchange Limited (SEL) is a financial market infrastructure, operating equity, derivatives, and fixed income markets. It offers trading, listing, settlement, clearing, depositary, and data services, with approximately 75% of listed bonds and 40% of listed companies and originating outside Singapore. SEL is a liquid offshore market for the benchmark equity indices of ASEAN members and non-members, including India, Japan, and China; and provides currency and commodity derivatives products. The company also offers data and market connectivity services. It serves clients globally through offices in Japan, South Korea, Taiwan, Hong Kong, the US, Germany, France, the UK, Switzerland, the Netherlands, and Singapore. SEL is headquartered in Singapore.

Singapore Exchange Limited Key Recent Developments

Apr 23,2018: SGX posts 3Q FY2018 net profit of S$100m
Apr 20,2018: SGX welcomes Asian Healthcare Specialists Limited to Catalist
Apr 04,2018: SGX hires bond veteran Mark Leahy as head of fixed income
Jan 19,2018: SGX reports 2Q FY2018 net profit of S$88 million
Nov 23,2017: SGX receives Exchange of the Year award from Energy Risk

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Singapore Exchange Limited – Key Facts 6
Singapore Exchange Limited – Key Employees 7
Singapore Exchange Limited – Key Employee Biographies 8
Singapore Exchange Limited – Major Products and Services 9
Singapore Exchange Limited – History 10
Singapore Exchange Limited – Company Statement 14
Singapore Exchange Limited – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 19
Company Overview 19
Singapore Exchange Limited – Business Description 20
Business Segment: Corporate 20
Overview 20
Performance 20
Key Stats 20
Business Segment: Derivatives 20
Overview 20
Performance 20
Key Strategies 20
Key Stats 21
Business Segment: EFI 21
Overview 21
Performance 21
Key Strategies 21
Key Stats 21
Business Segment: MDC 22
Overview 22
Performance 22
Key Strategies 22
Key Stats 22
Singapore Exchange Limited – SWOT Analysis 23
SWOT Analysis – Overview 23
Singapore Exchange Limited – Strengths 23
Singapore Exchange Limited – Weaknesses 24
Singapore Exchange Limited – Opportunities 25
Singapore Exchange Limited – Threats 26
Singapore Exchange Limited – Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios – Capital Market Ratios 28
Financial Ratios – Annual Ratios 29
Performance Chart 31
Financial Performance 31
Financial Ratios – Interim Ratios 32
Financial Ratios – Ratio Charts 33
Section 4 – Company’s Recent Developments 34
Apr 20, 2018: SGX welcomes Asian Healthcare Specialists Limited to Catalist 34
Jan 19, 2018: SGX reports 2Q FY2018 net profit of S$88 million 35
Oct 25, 2017: SGX reports 1Q FY2018 net profit of S$91 million 37
Sep 27, 2017: SGX named Derivatives Exchange of the Year 39
Jan 19, 2017: Singapore Exchange Q2 profit increases 40
Section 5 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Singapore Exchange Limited, Key Facts 6
Singapore Exchange Limited, Key Employees 7
Singapore Exchange Limited, Key Employee Biographies 8
Singapore Exchange Limited, Major Products and Services 9
Singapore Exchange Limited, History 10
Singapore Exchange Limited, Other Locations 17
Singapore Exchange Limited, Subsidiaries 18
Singapore Exchange Limited, Key Competitors 27
Singapore Exchange Limited, Ratios based on current share price 28
Singapore Exchange Limited, Annual Ratios 29
Singapore Exchange Limited, Annual Ratios (Cont...1) 30
Singapore Exchange Limited, Interim Ratios 32
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Singapore Exchange Limited, Performance Chart (2014 - 2018) 31
Singapore Exchange Limited, Ratio Charts 33

★海外企業調査レポート[Singapore Exchange Limited (S68):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intrexon Corp (XON)-製薬・医療分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Fujifilm Corp:企業の戦略的SWOT分析
    Fujifilm Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Evotec AG (EVT):製薬・医療:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Phoenix Petroleum Philippines Inc (PNX):石油・ガス:M&Aディール及び事業提携情報
    Summary Phoenix Petroleum Philippines Inc (PNX) is an independent oil and gas company that distributes petroleum products and lubricants. The company provides automotive fuels, biodiesel, gasoline and aviation fuels, among others. It offers services such as trading of refined petroleum products and …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務情報
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Astellas Pharma Inc (4503):医療機器:M&Aディール及び事業提携情報
    Summary Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, inf …
  • Lufthansa Cityline Gmbh:企業の戦略・SWOT・財務情報
    Lufthansa Cityline Gmbh - Strategy, SWOT and Corporate Finance Report Summary Lufthansa Cityline Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mount Tam Biotechnologies Inc (MNTM)-製薬・医療分野:企業M&A・提携分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamyci …
  • Qube Holdings Ltd:戦略・SWOT・企業財務分析
    Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • High Peak Royalties Ltd (HPR):石油・ガス:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Mgm China Holdings Ltd:企業の戦略・SWOT・財務分析
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Gland Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Revance Therapeutics Inc (RVNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Gevo Inc (GEVO):企業の財務・戦略的SWOT分析
    Summary Gevo Inc (Gevo) is a renewable chemicals and advanced biofuels company that offers renewable chemicals and biofuels. The company’s products include carbon cycle products, low carbon renewable jet fuels, renewable gasoline, isobutanol blendstocks, ingredient products, animal feed and proteins …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • IRPC Public Company Limited:企業の戦略・SWOT・財務情報
    IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Green Dot Corporation:企業の戦略・SWOT・財務分析
    Green Dot Corporation - Strategy, SWOT and Corporate Finance Report Summary Green Dot Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Metacrine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Metacrine Inc (Metacrine) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for the treatment of patients with liver and gastrointestinal diseases. The company develops its proprietary portfolio of non-bile acid FXR agonists through its chemistry and …
  • Bunzl plc (BNZL):医療機器:M&Aディール及び事業提携情報
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company. The company offer its customers with a unique business concept, which provides individual solutions along the supply chain to a variety of businesses and numerous goods around the world. It supplies a broad range of non-food …
  • Rakon Limited (RAK):企業の財務・戦略的SWOT分析
    Rakon Limited (RAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆